Time flies with great content! Renew in to keep enjoying all our premium content.
Prime
Sh1 million drug offers hope for patients with aggressive prostate cancer
Each treatment cycle costs between $8,000 and $10,000 (Sh1 million to Sh1.3 million). A patient needs at least four to six cycles, which means a person needs at least Sh4 million to Sh6 million.
Men with aggressive prostate cancer, often left with few options after chemotherapy fails, now have access to a new treatment that uses a radioactive substance.
The new treatment, Lutetium-177 PSMA therapy, relies on a radioactive molecule to target a protein found on the surface of prostate cancer cells. When injected into a patient’s body, it destroys the cancerous cells which have resisted other treatments.
